Navigation Links
Facilitating transparency in spinal cord injury studies using recognized information standards
Date:7/30/2014

Progress in developing robust therapies for spinal cord injury (SCI), traumatic brain injury (TBI) and peripheral nerve injury has been slow. A great deal has been learned over the past 30 years regarding both the intrinsic factors and the environmental factors that regulate axon growth, but this large body of information has not yet resulted in clinically available therapeutics. Prof. Lemmon and his team from University of Miami in USA proposed this therapeutic bottleneck has many root causes, but a consensus is emerging that one contributing factor is a lack of standards for experimental design and reporting. The absence of reporting standards, and even of commonly accepted definitions of key words, also make data mining and bioinformatics analysis of neural plasticity and regeneration difficult, if not impossible. These findings, published in the Neural Regeneration Research (Vol. 9, No. 1, 2014), this short review will consider relevant background and potential solutions to this problem in the axon regeneration domain.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. The first goat genome sets a good example for facilitating de novo assembly of large genomes
2. Global Thermal Imaging Market Expected to Reach USD 6,098.8 Million in 2019: Transparency Market Research
3. Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research
4. Healthcare Biometrics Market is Expected to Reach USD 5.8 Billion Globally in 2019: Transparency Market Research
5. Neurologic recovery from corticospinal tract injury due to subfalcine herniation
6. Intranasal nerve growth factor repairs injured spinal cord neurons
7. Gene therapy extends survival in an animal model of spinal muscular atrophy
8. Studies identify spinal cord neurons that control skilled limb movement
9. Kessler Foundation awarded Department of Defense grant for spinal cord injury research
10. Spinal stimulation helps 4 patients with paraplegia regain voluntary movement
11. Early rehabilitation improves postsurgery neurofunctional outcome in spinal tumor children
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Facilitating transparency in spinal cord injury studies using recognized information standards
(Date:5/26/2020)... ... May 26, 2020 , ... ... for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology ... T cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ® ...
(Date:5/21/2020)... ... , ... Law Enforcement has always been a highly stressful career – serving ... these men and women put them constantly in harm’s way both from the criminal ... always had to face very high daily stress. Now, COVID-19 introduces another even greater ...
(Date:5/14/2020)... ... May 14, 2020 , ... The annual salary report by ... 2019 average medical sales rep total compensation increased by $12,000 over the previous ... COVID-19 global crisis. , The MedReps 2020 Salary Survey revealed yet again there’s ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... (PRWEB) , ... April 06, 2020 , ... Gateway ... future children, reached 200,000 SneakPeek Early Gender DNA Tests sold in March, ... was launched as an ecommerce product, where a mom could order her kit ...
(Date:4/1/2020)... Texas (PRWEB) , ... March 30, 2020 , ... ... (APMD) and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to ... COVID-19 pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an ...
(Date:4/1/2020)... ... 31, 2020 , ... Bedoukian Research, Inc. (BRI) ... Development Agreement that builds on each company’s expertise in developing efficient routes to ... supply of high-quality insect pheromones as well as flavors and fragrances. P2 has ...
(Date:3/19/2020)... ... March 17, 2020 , ... ... manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) ... cancer and other solid tumor indications. The collaboration will leverage RoosterBio’s human ...
Breaking Biology Technology: